These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 19833407

  • 1. Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease.
    O'Sullivan SE, Kendall DA.
    Immunobiology; 2010 Aug; 215(8):611-6. PubMed ID: 19833407
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2.
    McHugh D, Tanner C, Mechoulam R, Pertwee RG, Ross RA.
    Mol Pharmacol; 2008 Feb; 73(2):441-50. PubMed ID: 17965195
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inflammatory reaction versus endogenous peroxisome proliferator-activated receptors expression, re-exploring secondary organ complications of spontaneously hypertensive rats.
    Sun L, Ke Y, Zhu CY, Tang N, Tian DK, Gao YH, Zheng JP, Bian K.
    Chin Med J (Engl); 2008 Nov 20; 121(22):2305-11. PubMed ID: 19080338
    [Abstract] [Full Text] [Related]

  • 7. Cannabinoids and PPARalpha signalling.
    Sun Y, Alexander SP, Kendall DA, Bennett AJ.
    Biochem Soc Trans; 2006 Dec 20; 34(Pt 6):1095-7. PubMed ID: 17073758
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cannabinoid system and neuroinflammation: implications for multiple sclerosis.
    Correa F, Docagne F, Mestre L, Loría F, Hernangómez M, Borrell J, Guaza C.
    Neuroimmunomodulation; 2007 Dec 20; 14(3-4):182-7. PubMed ID: 18073512
    [Abstract] [Full Text] [Related]

  • 11. The neurobiology and evolution of cannabinoid signalling.
    Elphick MR, Egertová M.
    Philos Trans R Soc Lond B Biol Sci; 2001 Mar 29; 356(1407):381-408. PubMed ID: 11316486
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?
    Oesch S, Gertsch J.
    J Pharm Pharmacol; 2009 Jul 29; 61(7):839-53. PubMed ID: 19589225
    [Abstract] [Full Text] [Related]

  • 18. Phospholipase A2-modified low-density lipoprotein activates macrophage peroxisome proliferator-activated receptors.
    Namgaladze D, Morbitzer D, von Knethen A, Brüne B.
    Arterioscler Thromb Vasc Biol; 2010 Feb 29; 30(2):313-20. PubMed ID: 19948841
    [Abstract] [Full Text] [Related]

  • 19. The role of the CB1 receptor in the regulation of sleep.
    Murillo-Rodríguez E.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug 01; 32(6):1420-7. PubMed ID: 18514375
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.